Douglas G. McNeel, MD of @UWCarbone discusses the phase II trial of a DNA vaccine encoding in patients with nonmetastatic, castration-sensitive prostate cancer. How does this affect treatment and clinicians today?
______
Read here: https://ascopubs.org/doi/abs/10.1200/JCO.19.01701?journalCode=jco&